Immunocore Holdings plc (IMCR) Misses Q4 EPS by 23c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q4 EPS of ($0.47), $0.23 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $84.05 million versus the consensus estimate of $84.53 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Wells Fargo Starts Sunbelt Rentals (SUNB) at Overweight
• Regional Management (RM) Reiterated at Market Outperform by Citizens After Price Reset